stars 1 stars 2 stars 3

Equigerminal is a certified R&D biotech company based in Penela, Portugal, focused on advancing animal health and One Health integration through science, technology, and ethics. We develop genetic, molecular and digital tools for preventive and precision veterinary medicine — from our diagnostic platforms to our digital twin ecosystem (CIICOH) and the AI-powered health assistant (AImals). We believe in science with soul, and in co-creating a future where animals live longer, healthier lives alongside humans — guided by ethics, innovation and data. Join us as we build the next chapter in veterinary biotechnology and integrative intelligence.

Equigerminal Questions

The Equigerminal annual revenue was $1 million in 2026.

Isabel Fidalgo Carvalho is the Co-founder and CEO, EQUIGERMINAL, S.A. of Equigerminal.

1 people are employed at Equigerminal.

Equigerminal is based in Coimbra, Coimbra.

The NAICS codes for Equigerminal are [621, 62151, 62, 6215].

The SIC codes for Equigerminal are [807, 80].

Top Equigerminal Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users